American Century Companies
HCAT icon

American Century Companies’s Health Catalyst HCAT Stock Holding History

American Century Companies’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-112,810
Closed -$143K – 2940
2026
Q1 		$143K Sell
112,810
-19,327
-15% -$36.4K ﹤0.01% 2748
2025
Q4 		$316K Sell
132,137
-19,731
-13% -$54K ﹤0.01% 2626
2025
Q3 		$433K Buy
151,868
+3,010
+2% +$10.3K ﹤0.01% 2550
2025
Q2 		$561K Buy
148,858
+30,884
+26% +$121K ﹤0.01% 2486
2025
Q1 		$534K Sell
117,974
-592,507
-83% -$3.14M ﹤0.01% 2483
2024
Q4 		$5.02M Buy
710,481
+12,682
+2% +$101K ﹤0.01% 1602
2024
Q3 		$5.68M Buy
697,799
+14,335
+2% +$104K ﹤0.01% 1526
2024
Q2 		$4.37M Buy
683,464
+9,466
+1% +$60.8K ﹤0.01% 1556
2024
Q1 		$5.08M Buy
673,998
+17,662
+3% +$161K ﹤0.01% 1444
2023
Q4 		$6.08M Sell
656,336
-1,216
-0.2% -$9.94K ﹤0.01% 1340
2023
Q3 		$6.65M Buy
657,552
+62,010
+10% +$740K 0.01% 1229
2023
Q2 		$7.44M Buy
595,542
+12,507
+2% +$149K 0.01% 1167
2023
Q1 		$6.8M Buy
583,035
+11,221
+2% +$143K 0.01% 1150
2022
Q4 		$6.08M Buy
571,814
+5,825
+1% +$56.2K 0.01% 1153
2022
Q3 		$5.49M Sell
565,989
-748,173
-57% -$9.91M ﹤0.01% 1079
2022
Q2 		$19M Buy
1,314,162
+162,512
+14% +$2.77M 0.02% 685
2022
Q1 		$30.1M Buy
1,151,650
+120,289
+12% +$3.41M 0.02% 587
2021
Q4 		$40.9M Buy
1,031,361
+49,999
+5% +$2.28M 0.03% 521
2021
Q3 		$49.1M Sell
981,362
-84,347
-8% -$4.6M 0.03% 460
2021
Q2 		$59.2M Sell
1,065,709
-79,054
-7% -$4.21M 0.04% 432
2021
Q1 		$53.5M Buy
1,144,763
+195,914
+21% +$9.49M 0.04% 425
2020
Q4 		$41.3M Sell
948,849
-4,291
-0.5% -$158K 0.03% 437
2020
Q3 		$34.9M Sell
953,140
-19,834
-2% -$674K 0.03% 425
2020
Q2 		$28.4M Buy
972,974
+198,605
+26% +$5.49M 0.03% 442
2020
Q1 		$20.3M Sell
774,369
-25,545
-3% -$780K 0.02% 446
2019
Q4 		$27.8M Buy
799,914
+290,320
+57% +$9.61M 0.03% 442
2019
Q3 		$16.1M Buy
+509,594
New +$20.1M 0.02% 526

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $239M AUM
PVM
Palogic Value Management Dallas, Texas $304M AUM 15.15% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies's HCAT Position: Q2 2026 in Review

American Century Companies sold out of Health Catalyst (HCAT) in Q2 2026, closing a stake of 112,810 shares — an estimated $143K sold.

American Century Companies first reported a position in HCAT in Q3 2019 and held it in 27 quarters. The position peaked at $59.2M in Q2 2021. 126 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • American Century Companies reported no remaining Health Catalyst position as of Q2 2026 after selling out during the quarter.
  • American Century Companies sold 112,810 Health Catalyst shares in Q2 2026, an estimated $143K.
  • American Century Companies first reported a position in Health Catalyst in Q3 2019 and held it in 27 quarters.
  • American Century Companies's Health Catalyst position peaked at $59.2M in Q2 2021.
  • 126 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.